We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Steroid-Like Hormone Prompts Change of Morphology in Parasitic Nematodes

By HospiMedica International staff writers
Posted on 09 Jun 2009
Researchers have identified a chemical compound that causes parasitic nematode worms to morph prematurely into the stage requiring feeding from host tissue, which results in the worms starving to death before they can establish an infection.

According to the World Health Organization (Geneva, Switzerland), parasitic nematodes infect about two billion people worldwide and severely sicken some 300 million, at least 50% being school-age children.

Investigators from the University of Texas Southwestern Medical Center (Dallas, USA) worked with the free-living worm Caenorhabditis elegans as well as with the parasitic nematode Strongyloides stercoralis. More...
Following up on previous studies showing that the steroid-like hormone dafachronic acid prompted worm larvae to mature from the stage in which they infect a host to the stage in which they start feeding on the host, the investigators sought to establish the molecular mechanism basis for this effect.

The researchers reported in the June 2, 2009, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) that they used X-ray crystallography to solve the three-dimensional structure of the S. stercoralis nuclear receptor DAF-12 ligand-binding domain cocrystallized with dafachronic acids. This data revealed the molecular basis for DAF-12 ligand binding and identified nuclear receptors as unique therapeutic targets in parasitic nematodes.

The next step is to screen large libraries of chemicals to search for compounds that behave like dafachronic acid and that could possibly be developed into pesticides that could be spread in high-infection areas.

"What keeps these parasites infectious is the lack of production of dafachronic acid,” said senior author Dr. David Mangelsdorf, professor of pharmacology at the University of Texas Southwestern Medical Center. "Once they get inside the host, however, something switches them on to begin making this compound. We can interrupt the worm's life cycle just by giving it this compound when it is in the infectious state, before it enters a host.”

Related Links:
World Health Organization
University of Texas Southwestern Medical Center



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.